Literature DB >> 23387435

Galanin-induced decreases in nucleus accumbens/striatum excitatory postsynaptic potentials and morphine conditioned place preference require both galanin receptor 1 and galanin receptor 2.

Emily B Einstein1, Yukiko Asaka, Mark F Yeckel, Michael J Higley, Marina R Picciotto.   

Abstract

The neuropeptide galanin has been shown to alter the rewarding properties of morphine. To identify potential cellular mechanisms that might be involved in the ability of galanin to modulate opiate reward, we measured excitatory postsynaptic potentials (EPSPs), using both field and whole-cell recordings from striatal brain slices extracted from wild-type mice and mice lacking specific galanin receptor (GalR) subtypes. We found that galanin decreased the amplitude of EPSPs in both the dorsal striatum and nucleus accumbens. We then performed recordings in slices from knockout mice lacking either the GalR1 or GalR2 gene, and found that the ability of galanin to decrease EPSP amplitude was absent from both mouse lines, suggesting that both receptor subtypes are required for this effect. In order to determine whether behavioral responses to opiates were dependent on the same receptor subtypes, we tested GalR1 and GalR2 knockout mice for morphine conditioned place preference (CPP). Morphine CPP was significantly attenuated in both GalR1 and GalR2 knockout mice. These data suggest that mesolimbic excitatory signaling is significantly modulated by galanin in a GalR1-dependent and GalR2-dependent manner, and that morphine CPP is dependent on the same receptor subtypes.
© 2013 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23387435      PMCID: PMC3648588          DOI: 10.1111/ejn.12151

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  54 in total

1.  Interactions of galanin and morphine in the spinal antinociception in rats with mononeuropathy.

Authors:  Y P Zhang; T Lundeberg; L C Yu
Journal:  Brain Res       Date:  2000-01-10       Impact factor: 3.252

2.  Effects of galanin receptor agonists on locus coeruleus neurons.

Authors:  X Ma; Y G Tong; R Schmidt; W Brown; K Payza; L Hodzic; C Pou; C Godbout; T Hökfelt; Z Q Xu
Journal:  Brain Res       Date:  2001-11-16       Impact factor: 3.252

3.  Critical role for GALR1 galanin receptor in galanin regulation of neuroendocrine function and seizure activity.

Authors:  Arie Steven Jacoby; Yvonne Janet Hort; George Constantinescu; John Shine; Tiina Pauline Iismaa
Journal:  Brain Res Mol Brain Res       Date:  2002-11-15

Review 4.  Optogenetic modulation of neural circuits that underlie reward seeking.

Authors:  Garret D Stuber; Jonathan P Britt; Antonello Bonci
Journal:  Biol Psychiatry       Date:  2011-12-22       Impact factor: 13.382

5.  Anticonvulsant activity of a nonpeptide galanin receptor agonist.

Authors:  Külliki Saar; Andrey M Mazarati; Riina Mahlapuu; Gerd Hallnemo; Ursel Soomets; Kalle Kilk; Sven Hellberg; Margus Pooga; Bo-Ragnar Tolf; Tiejun S Shi; Tomas Hökfelt; Claude Wasterlain; Tamas Bartfai; Ulo Langel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

6.  Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine.

Authors:  R T Matthews; D C German
Journal:  Neuroscience       Date:  1984-03       Impact factor: 3.590

Review 7.  Molecular neurobiology of drug addiction.

Authors:  Jennifer Chao; Eric J Nestler
Journal:  Annu Rev Med       Date:  2004       Impact factor: 13.739

8.  Taurine-induced long-lasting enhancement of synaptic transmission in mice: role of transporters.

Authors:  O A Sergeeva; A N Chepkova; N Doreulee; K S Eriksson; W Poelchen; I Mönnighoff; B Heller-Stilb; U Warskulat; D Häussinger; H L Haas
Journal:  J Physiol       Date:  2003-06-24       Impact factor: 5.182

9.  Obesity and endocrine dysfunction in mice with deletions of both neuropeptide Y and galanin.

Authors:  J G Hohmann; D N Teklemichael; D Weinshenker; D Wynick; D K Clifton; R A Steiner
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

10.  Galanin acts at GalR1 receptors in spinal antinociception: synergy with morphine and AP-5.

Authors:  Xiao-Ying Hua; Carol S Hayes; Anthony Hofer; Bethany Fitzsimmons; Kalle Kilk; Ulo Langel; Tamas Bartfai; Tony L Yaksh
Journal:  J Pharmacol Exp Ther       Date:  2003-11-10       Impact factor: 4.030

View more
  8 in total

1.  Hippocampal long-term potentiation is disrupted during expression and extinction but is restored after reinstatement of morphine place preference.

Authors:  George S Portugal; Ream Al-Hasani; Amanda K Fakira; Jose L Gonzalez-Romero; Zare Melyan; Jordan G McCall; Michael R Bruchas; Jose A Morón
Journal:  J Neurosci       Date:  2014-01-08       Impact factor: 6.167

2.  Chronic pain. Decreased motivation during chronic pain requires long-term depression in the nucleus accumbens.

Authors:  Neil Schwartz; Paul Temkin; Sandra Jurado; Byung Kook Lim; Boris D Heifets; Jai S Polepalli; Robert C Malenka
Journal:  Science       Date:  2014-08-01       Impact factor: 47.728

3.  The galanin receptor agonist, galnon, attenuates cocaine-induced reinstatement and dopamine overflow in the frontal cortex.

Authors:  Yvonne E Ogbonmwan; Natale R Sciolino; Jessica L Groves-Chapman; Kimberly G Freeman; Jason P Schroeder; Gaylen L Edwards; Philip V Holmes; David Weinshenker
Journal:  Addict Biol       Date:  2014-07-23       Impact factor: 4.280

4.  Morphine Exposure Reduces Nicotine-Induced Upregulation of Nicotinic Receptors and Decreases Volitional Nicotine Intake in a Mouse Model.

Authors:  Alicia J Avelar; Skylar Y Cooper; Thomas Douglas Wright; Sheavonnie K Wright; Montana R Richardson; Brandon J Henderson
Journal:  Nicotine Tob Res       Date:  2022-07-13       Impact factor: 5.825

5.  Development of Spexin-based Human Galanin Receptor Type II-Specific Agonists with Increased Stability in Serum and Anxiolytic Effect in Mice.

Authors:  Arfaxad Reyes-Alcaraz; Yoo-Na Lee; Gi Hoon Son; Nam Hoon Kim; Dong-Kyu Kim; Seongsik Yun; Dong-Hoon Kim; Jong-Ik Hwang; Jae Young Seong
Journal:  Sci Rep       Date:  2016-02-24       Impact factor: 4.379

6.  Galanin receptor 3 attenuates inflammation and influences the gut microbiota in an experimental murine colitis model.

Authors:  Susanne M Brunner; Florian Reichmann; Julia Leitner; Soraya Wölfl; Stefan Bereswill; Aitak Farzi; Anna-Maria Schneider; Eckhard Klieser; Daniel Neureiter; Michael Emberger; Markus M Heimesaat; Daniel Weghuber; Roland Lang; Peter Holzer; Barbara Kofler
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

7.  Galanin Regulates Myocardial Mitochondrial ROS Homeostasis and Hypertrophic Remodeling Through GalR2.

Authors:  Frederic Boal; Mathieu Cinato; Andrei Timotin; Heike Münzberg; Emily Qualls-Creekmore; Solomiia Kramar; Halyna Loi; Jerome Roncalli; Sokhna Keita; Helene Tronchere; Oksana Kunduzova
Journal:  Front Pharmacol       Date:  2022-03-31       Impact factor: 5.810

8.  Green Apple e-Cigarette Flavorant Farnesene Triggers Reward-Related Behavior by Promoting High-Sensitivity nAChRs in the Ventral Tegmental Area.

Authors:  Skylar Y Cooper; Austin T Akers; Brandon J Henderson
Journal:  eNeuro       Date:  2020-08-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.